Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…Both <b>1a</b> and <b>3a</b> react with anaerobic NO(g) to give the corresponding <i>N</i>-aryl-<i>N</i>-nitrosohydroxylaminato complexes [Me₂NN]M(κ²-O₂N₂Ar) [M = Ni (<b>4</b>), Cu (<b>5</b>)]. …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…Both <b>1a</b> and <b>3a</b> react with anaerobic NO(g) to give the corresponding <i>N</i>-aryl-<i>N</i>-nitrosohydroxylaminato complexes [Me₂NN]M(κ²-O₂N₂Ar) [M = Ni (<b>4</b>), Cu (<b>5</b>)]. …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…Both <b>1a</b> and <b>3a</b> react with anaerobic NO(g) to give the corresponding <i>N</i>-aryl-<i>N</i>-nitrosohydroxylaminato complexes [Me₂NN]M(κ²-O₂N₂Ar) [M = Ni (<b>4</b>), Cu (<b>5</b>)]. …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…Both <b>1a</b> and <b>3a</b> react with anaerobic NO(g) to give the corresponding <i>N</i>-aryl-<i>N</i>-nitrosohydroxylaminato complexes [Me₂NN]M(κ²-O₂N₂Ar) [M = Ni (<b>4</b>), Cu (<b>5</b>)]. …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…Both <b>1a</b> and <b>3a</b> react with anaerobic NO(g) to give the corresponding <i>N</i>-aryl-<i>N</i>-nitrosohydroxylaminato complexes [Me₂NN]M(κ²-O₂N₂Ar) [M = Ni (<b>4</b>), Cu (<b>5</b>)]. …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…Both <b>1a</b> and <b>3a</b> react with anaerobic NO(g) to give the corresponding <i>N</i>-aryl-<i>N</i>-nitrosohydroxylaminato complexes [Me₂NN]M(κ²-O₂N₂Ar) [M = Ni (<b>4</b>), Cu (<b>5</b>)]. …”

A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

“…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”

VEGF mutants demonstrated increased VE-cadherin expression compared to littermates, while sFlt-1 mutants demonstrated decreased expression. by Christopher R. Schlieve (3179439)

Effect sizes (if > 0.5) for the comparison of increasing load vs. decreasing for the iliocostalis muscle. by Christoph Anders (4068499)

Increased expression of Fz5 receptor matched with a decrease in NeuN immunoreactivity at 16w. by Carlos González-Fernández (2794207)

A prepubertal CD decreases hepatic DNA methylation and increases hydroxymethylation in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

(A) The temperature sensitive allele of <i>HEM1</i> leads to a significant decrease in the endogenous levels of Cia2 and Mms19. by Ifat Lev (469072)

SARS-CoV-2 specific T cell frequencies analysis comparing pre-existing conditions show no significant differences. by Katherine M. Littlefield (12647420)

Colored points represent the dates where events from Fig 7, have a <i>p</i>-value below the <i>α</i> = 0.05 significance level, i.e. dates where the statistical behavior of the dur... by Héctor Raúl Olivares-Sánchez (13014866)

Table_1_A phased intervention bundle to decrease the mortality of patients with extracorporeal membrane oxygenation in intensive care unit.pdf by Yajun Jing (11711139)

“…In multivariable analysis, even after excluding the confounding factors, such as age, APECHII score, pre-ECMO lactate, and incidence of CRRT during ECMO, the intervention bundle still can decrease the mortality independently, which also remained true in the statistical analysis of V-V and V-A ECMO separately. …”

Amplitude for A/L = 0.29. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.338. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

Subjects:

Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

Subjects:

Assessment of cell proliferation within the vocal fold muscle following DFATs transplantation. by Ikuo Mikoshiba (9312007)

Subjects: